Fairmount Funds Management LLC
Position in FTH — Faeth Therapeutics, Inc.
CIK 1802528
WEST CONSHOHOCKEN, PA
Position in FTH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,050,500
New position
Shares Held
722,020
first reported quarter
Ownership
2.79%
of shares outstanding
% of Portfolio
1.19%
of 13F equity value
Holder Rank
#9
of 45 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Fairmount Funds Management LLC holds $1,512,967,792 across 12 Biotechnology names. FTH ranks #11 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ORKA |
Oruka Therapeutics, Inc.
|
3,705,262 | $352,629,784 | |
| 2 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
2,537,191 | $247,325,378 | |
| 3 | DMRA |
Damora Therapeutics, Inc.
|
8,713,000 | $226,625,130 | |
| 4 | COGT |
Cogent Biosciences, Inc.
|
5,503,418 | $212,982,276 | |
| 5 | JBIO |
Jade Biosciences, Inc.
|
4,553,494 | $101,178,636 | |
| 6 | ELVN |
Enliven Therapeutics, Inc.
|
1,855,644 | $94,173,933 | |
| 7 | VRDN |
Viridian Therapeutics, Inc.\DE
|
5,090,928 | $93,520,347 | |
| 8 | ZBIO |
Zenas BioPharma, Inc.
|
2,359,025 | $59,872,054 |
All Filings in FTH
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,050,500 | 722,020 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||